Old Web
English
Sign In
Acemap
>
authorDetail
>
A. Ruth He
A. Ruth He
Georgetown University Medical Center
Population
Internal medicine
Medicine
Pathology
Colorectal cancer
3
Papers
77
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies.
2021
Cancer Medicine
Neel D. Trivedi
Samantha Armstrong
Hongkun Wang
Marion L. Hartley
John F. Deeken
A. Ruth He
Deepa S. Subramaniam
Heather Melville
Chris Albanese
John L. Marshall
Jimmy Hwang
Michael J Pishvaian
Show All
Source
Cite
Save
Citations (3)
A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer
2018
Cancer
Michael J. Pishvaian
Rebecca S. Slack
Wei Jiang
A. Ruth He
Jimmy J. Hwang
Amy Hankin
Karen Dorsch-Vogel
Divyesh Kukadiya
Louis M. Weiner
John L. Marshall
Jonathan R. Brody
Show All
Source
Cite
Save
Citations (30)
A Phase 1 Study of Efatutazone, an Oral Peroxisome Proliferator-Activated Receptor Gamma Agonist, Administered to Patients With Advanced Malignancies
2012
Cancer
Michael J. Pishvaian
John L. Marshall
Andrew J. Wagner
Jimmy J. Hwang
Shakun Malik
Ion Cotarla
John F. Deeken
A. Ruth He
Hirut Daniel
Abdel-Baset Halim
Hamim Zahir
Catherine Copigneaux
Kejian Liu
Robert A. Beckman
George D. Demetri
Show All
Source
Cite
Save
Citations (44)
1